Ji et al. have also found that heparan sulfate 3-O-sulfotransferase 1 (HS3ST1) inhibits SPOP expression and also inhibits activation of the NF-κB pathway activation mediated by FADD degradation in NSCLC [139]. The gene discussed is SPOP; the disease is non-small cell lung carcinoma.